middle.news
How Bioxyne’s €3.2M German Deal Fuels Record Revenue Surge
9:18am on Thursday 24th of July, 2025 AEST
•
Pharmaceuticals
Read Story
How Bioxyne’s €3.2M German Deal Fuels Record Revenue Surge
9:18am on Thursday 24th of July, 2025 AEST
Key Points
Q4 FY25 revenue hits $9.5 million, up 204% year-on-year
FY25 unaudited revenue of $29.3 million exceeds guidance by $1.3 million
Positive operating cash flow of $1.5 million in Q4
€3.2 million manufacturing and supply contract secured in Germany
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bioxyne (ASX:BXN)
OPEN ARTICLE